United Pharm (033270) - Total Liabilities

Latest as of December 2025: ₩64.86 Billion KRW ≈ $43.96 Million USD

Based on the latest financial reports, United Pharm (033270) has total liabilities worth ₩64.86 Billion KRW (≈ $43.96 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore United Pharm cash flow conversion to assess how effectively this company generates cash.

United Pharm - Total Liabilities Trend (2011–2025)

This chart illustrates how United Pharm's total liabilities have evolved over time, based on quarterly financial data. Check United Pharm liquidity resilience to evaluate the company's liquid asset resilience ratio.

United Pharm Competitors by Total Liabilities

The table below lists competitors of United Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Samyoung Elec KO:005680	Korea	₩22.57 Billion
Ceragon Networks Ltd NASDAQ:CRNT	USA	$144.29 Million
SNS KLSE:0259	Malaysia	RM383.01 Million
Quang Viet Enterprise Co Ltd TW:4438	Taiwan	NT$12.00 Billion
Catella AB (publ) ST:CAT-B	Sweden	Skr2.18 Billion
i-SENS Inc KQ:099190	Korea	₩238.13 Billion
Atomera Inc NASDAQ:ATOM	USA	$2.71 Million
Aurora Cannabis Inc NASDAQ:ACB	USA	$207.47 Million

Liability Composition Analysis (2011–2025)

This chart breaks down United Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see United Pharm stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how United Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for United Pharm (2011–2025)

The table below shows the annual total liabilities of United Pharm from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩64.86 Billion ≈ $43.96 Million	-4.22%
2024-12-31	₩67.72 Billion ≈ $45.89 Million	-24.90%
2023-12-31	₩90.18 Billion ≈ $61.11 Million	+12.68%
2022-12-31	₩80.03 Billion ≈ $54.24 Million	+0.90%
2021-12-31	₩79.32 Billion ≈ $53.76 Million	+3.63%
2020-12-31	₩76.54 Billion ≈ $51.87 Million	+0.52%
2019-12-31	₩76.14 Billion ≈ $51.60 Million	+3.64%
2018-12-31	₩73.47 Billion ≈ $49.79 Million	+14.59%
2017-12-31	₩64.11 Billion ≈ $43.45 Million	+12.81%
2016-12-31	₩56.83 Billion ≈ $38.52 Million	+2.84%
2014-12-31	₩55.27 Billion ≈ $37.45 Million	+6.07%
2013-12-31	₩52.10 Billion ≈ $35.31 Million	-3.69%
2012-12-31	₩54.10 Billion ≈ $36.66 Million	-5.16%
2011-12-31	₩57.04 Billion ≈ $38.66 Million	--

About United Pharm

KO:033270 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$197.70 Million

₩291.72 Billion KRW

Market Cap Rank

#16575 Global

#704 in Korea

Share Price

₩20200.00

Change (1 day)

-1.70%

52-Week Range

₩18130.00 - ₩22350.00

All Time High

₩95918.11